The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
diclofenac epolamine 1.3% patch · System
1 marketed package NDCs · 1 active manufacturer
Same drug class
Other molecules FDA puts in Nonsteroidal Anti-inflammatory Drug, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- ketorolac tromethamine· in shortage
- acetaminophen , aspirin and caffeine· 1 maker
- acetaminophen 250 mg and ibuprofen 125 mg· 1 maker
- acetaminophen 250 mg aspirin 250 mg caffeine 65 mg· 1 maker
- acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg· 1 maker
- acetaminophen 250mg, aspirin 250mg and caffeine 65mg· 1 maker
- acetaminophen and asprin· 1 maker
- acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg· 1 maker
- acetaminophen and ibuprofen injection· 1 maker
- acetaminophen-aspirin-caffeine· 1 maker
- acetaminophen, aspirin (nsaid) and diphenhydramine citrate· 1 maker
- acetaminophen, aspirin, caffeine tablet· 1 maker
Common questions
- Is Diclofenac epolamine 1.3% patch in shortage right now?
- No. FDA does not currently list Diclofenac epolamine 1.3% patch in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Diclofenac epolamine 1.3% patch?
- 1 company has marketed Diclofenac epolamine 1.3% patch in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.